CRT grants rights for targeting technology to Aura

10th December 2009

Scientists scoop top prize for light-based detection technology

13th October 2009

CRT to Licence Telomere Targeting Agents to Pharminox for Drug Development

5th October 2009

Cancer Research UK and AstraZeneca to Accelerate Biomarker Research

5th October 2009

CRT Facilitates Collaboration Between Duke University and Cancer Therapeutics CRC

13th July 2009

New Alliance for Discovery of WNT Pathway Inhibitors to be Used in Cancer Therapy

22nd June 2009

Initiation of global Phase III clinical study by Merck KGaA of the Therapeutic Cancer Vaccine Stimuvax® in Patients with Breast Cancer

7th June 2009

Innovative Partnership Targets Cancer-causing 'Chaperones'

26th May 2009

Cambridge Research Institute Attracts GSK Backing for Novel Therapeutic Collaboration

21st May 2009

Cancer Research Technology Selects Maybridge Fragments for Lead Discovery Programmes

20th May 2009

Cancer Research UK and GlaxoSmithKline Join Forces to Trial New Anti-Cancer Drug

15th May 2009

CRT, Newcastle University and Kudos Advance DNA-PK Research with a New Licence

19th April 2009

Potential New Drug Blocks Pathway of Deadliest Cancers

2nd March 2009

New Deal Boosts Development of Targeting Peptides in Nanotechnology

6th February 2009

Temozolomide Sales Reach $1 Billion

5th January 2009

Dr. Melanie Lee was awarded Commander of the Order of the British Empire (CBE) in the 2009 New Years Honours list. Dr. Lee is the Chairman of CRT and deputy Chairman of Cancer Research UK.